Unleash the Cell Potential.
Metcela Inc. is at the forefront of biotechnology research, dedicated to revolutionizing the treatment of heart failure. With a focus on harnessing the power of specific fibroblast cells, known as VCF, Metcela Inc. aims to develop and commercialize an effective and reasonably-priced therapy sourced directly from the patient’s own heart.
Located at 3 Chome-25-22 Tonomachi, Kawasaki, Kanagawa 210-0821, JP, Metcela Inc. takes a unique approach to heart failure therapy. Rather than replacing damaged tissue, the company focuses on repairing the damage by enhancing the cells’ natural ability to heal. This innovative method sets Metcela Inc. apart in the biotechnology field, promising groundbreaking advancements in patient care.
Metcela Inc. is committed to unleashing the full potential of cell therapy to combat heart failure and improve patient outcomes worldwide. We invite the manager of Metcela Inc. to create a customized and exclusive company showcase and product listing on our platform, enhancing their visibility and reach.
株式会社Metcelaは、バイオテクノロジー研究の最前線に立ち、心不全の治療に革命を起こすことに専念しています。特定の線維芽細胞(VCF)の力を活用することに焦点を当て、株式会社Metcelaは、患者自身の心臓から直接採取した、効果的でリーズナブルな価格の治療法を開発し、商業化することを目指しています。
株式会社Metcelaは、神奈川県川崎市川崎区殿町3丁目25-22に位置し、心不全治療に対する独自のアプローチを取っています。損傷した組織を置き換えるのではなく、細胞の自然治癒力を高めることで損傷の修復に焦点を当てています。この革新的な方法は、バイオテクノロジー分野における株式会社Metcelaを際立たせ、患者ケアにおける画期的な進歩を約束します。
株式会社Metcelaは、心不全と闘い、世界中の患者の転帰を改善するために、細胞療法の可能性を最大限に引き出すことに尽力しています。株式会社Metcelaのマネージャー様、ぜひ当社のプラットフォームでカスタマイズされた独占的な会社紹介と製品リストを作成し、貴社の認知度とリーチを向上させてください。
Compare Metcela Inc. with 3 companies in Biotechnology-Research
| Comparison Field |
Metcela Inc.Main Company |
CellaresView Profile |
3P Biopharmaceutical...View Profile |
UAE BioTech Symposiu...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2019 | 2006 | |
|
Company Size
|
— | 51-200 | 501-1,000 | 2-10 |
|
City
|
Kawasaki, Kanagawa | South San Francisco, California | Noáin, Navarra | |
|
Country
|
Japan | United States | ||
|
Skills & Keywords
Comparing with main company
|
10 Total Skills
Biotechnology
Cell Therapy
Heart Failure Treatment
Fibroblast Cells
Regenerative Medicine
Cardiovascular Research
Pharmaceutical Development
heart failure
cell therapy
biotechnology
|
10 Total
10 Unique
Unique Skills:
biotech
healthcare
manufacturing
medicine
patient care
patients
+4
|
22 Total
22 Unique
Unique Skills:
AAVs
advanced therapies
biologics
biosimilars
biotech
CDMO
+16
|
15 Total
15 Unique
Unique Skills:
abudhabi
biologics
biopharma
clinical trials
drug discovery
GCC
+9
|
Other organizations in the same industry
This company is also known as